InterCure Reschedules 2022 Full Year Results Conference Call
April 03 2023 - 2:27PM
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba
Canndoc)("InterCure" or the “Company”) announced today that it has
rescheduled its previously announced conference call to discuss the
company's financial results for the full year ended December 31,
2022.
The call was originally scheduled for April 3 at
4:30 P.M. (Eastren time) but has been rescheduled to April 4, at
4:30 P.M. (Eastren time) due to unforeseen circumstances which
caused technical issues.
Participants can access the live webcast and
conference call through the following link:
https://register.vevent.com/register/BIdec7603751894ebcbf0f22eca91cdb4a
About InterCure (dba
Canndoc)
InterCure (dba Canndoc) (NASDAQ: INCR) (TSX:
INCR.U) (TASE: INCR) is the leading, profitable, and fastest
growing cannabis company outside of North America. Canndoc, a
wholly owned subsidiary of InterCure, is Israel’s largest licensed
cannabis producer and one of the first to offer Good Manufacturing
Practices (GMP) certified and pharmaceutical-grade medical cannabis
products. InterCure leverages its international market leading
distribution network, best in class international partnerships and
a high-margin vertically integrated "seed-to-sale" model to lead
the fastest growing cannabis global market outside of North
America.
For more information,
visit: http://www.intercure.co.
Contact:
InterCure Ltd.Amos Cohen, Chief Financial
Officeramos@intercure.co
Intercure (TSX:INCR.U)
Historical Stock Chart
From Mar 2024 to Apr 2024
Intercure (TSX:INCR.U)
Historical Stock Chart
From Apr 2023 to Apr 2024